58MO Evaluation of Three Pexidartinib Doses in a Global Phase IV Clinical Study of Patients with Tenosynovial Giant Cell Tumor (TGCT) Who Chose to Continue Treatment
ESMO Open(2024)
关键词
Tenosynovial Giant Cell Tumor
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要